Vaccine News and Research

Latest Vaccine News and Research

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics, a novel family of synthetic anti-bacterial compounds, and anti-viral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum anti-influenza product into clinical studies.

27 Aug 2009

FDA releases consumer health information updates

The U.S. Food and Drug Administration today released its latest listing of consumer health information updates. All articles can be accessed from the agency's Web page for consumers. You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis. A Consumer Update RSS feed is also available.

27 Aug 2009

Asia will experience H1N1 vaccine shortage, WHO says

A spokesperson for the WHO said on Tuesday that Asia will not have enough H1N1 vaccines for swine flu when cold weather hits, Reuters reports.

26 Aug 2009

Important development in the treatment of multiple sclerosis

A major step forward, with important implications for understanding how to reduce the severity of multiple sclerosis, has been made by scientists at the University of Bristol. The results are published online today in PNAS.

26 Aug 2009

Lack of imagination and aversion to commercial risk are the biggest threats to Australia’s medical innovation

Australia could be a world leader in medical innovation but commercial risk aversion and parochialism are holding the industry back, a leading venture capitalist will argue at a public lecture and debate at the University of New South Wales next week (Monday, 31 August).

26 Aug 2009

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

NexBio, Inc. announced today the publication "DAS181 Inhibits H5N1 Influenza Lung Virus Infection of Human Lung Tissues" in the September, 2009 issue of the journal Antimicrobial Agents and Chemotherapy (AAC).

26 Aug 2009

Public and private sector players ready to tackle North America’s upcoming flu season

An MIT Sloan School of Management expert on U.S. vaccine markets is “cautiously hopeful” that public and private sector players are far better prepared for North America’s upcoming flu season than they have been for earlier flu pandemics.

26 Aug 2009

Report warns H1N1 could affect half of U.S. population

A U.S. presidential panel report released Monday estimates H1N1 (swine) flu could infect up to half of the country's population, the Washington Post reports.

26 Aug 2009

Antimicrobial-resistant typhoid fever in U.S. patients is associated with international travel

Infection with an antimicrobial-resistant strain of typhoid fever among patients in the United States is associated with international travel, especially to the Indian subcontinent (India, Pakistan, and Bangladesh), according to a study in the August 26 issue of JAMA. The study also shows an increase in certain strains of typhoid fever that are resistant to the most commonly used medications for treatment.

26 Aug 2009

Washington Post examines development of vaccine for food borne intestinal illness

The Partnership for Public Service/Washington Post examines how decades of work by Navy scientist Patricia Guerry could lead to "the first vaccine for a food borne intestinal illness that affects hundreds of millions of people worldwide each year."

26 Aug 2009

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept studies with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.

26 Aug 2009

Hiberix receives accelerated approval from FDA to overcome nationwide shortage

The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.

26 Aug 2009

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology.

25 Aug 2009

Free webinar for business travel industry on swine flu pandemic

"Business as usual” won’t be this flu season, with the effects of the H1N1 (Swine Flu) pandemic expected to include quarantines, travel restrictions and school and office closings. Businesses that rely on travel need to make preparations now to mitigate the impact.

25 Aug 2009

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

TuBerculosis Vaccine Initiative (TBVI) recently received a $3million grant for a three year term from the Bill & Melinda Gates Foundation. This grant enables the nonprofit organization to strengthen its fundraising and communication activities in order to increase awareness and support for tuberculosis (TB) vaccine research and raise funds for the development of safer and more effective vaccines.

25 Aug 2009

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Tripep and the German biotech company Cosmix AG have both licensed their respective technologies (RAS and mRNA Display Library) to a newly formed US company named Opsonic Therapeuticals Inc. within which Tripep’s RAS technology will be developed.

25 Aug 2009

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Bavarian Nordic A/S (OMX: BAVA) announced today that the US authorities have initiated negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE(R) smallpox vaccine.

25 Aug 2009

Combined therapy for acute leukemia shows promising results

Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.

25 Aug 2009

Unotron collaborates with GHA Technologies to supply washable data input devices

School systems throughout the nation have a strong ally in mitigating a resurgence of swine flu this fall. UNOTRON (www.unotron.com), worldwide creator of medical grade, washable computer keyboards, scroll wheel mice, and smartcard readers, announces that it is teaming up with GHA Technologies, Inc. (www.gha-associates.com) to offer Unotron’s high quality, washable data input and security devices.

25 Aug 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers.

25 Aug 2009

Vaccine News and Research

Latest Vaccine News and Research

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

FDA releases consumer health information updates

Asia will experience H1N1 vaccine shortage, WHO says

Important development in the treatment of multiple sclerosis

Lack of imagination and aversion to commercial risk are the biggest threats to Australia’s medical innovation

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

Public and private sector players ready to tackle North America’s upcoming flu season

Report warns H1N1 could affect half of U.S. population

Antimicrobial-resistant typhoid fever in U.S. patients is associated with international travel

Washington Post examines development of vaccine for food borne intestinal illness

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Hiberix receives accelerated approval from FDA to overcome nationwide shortage

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

Free webinar for business travel industry on swine flu pandemic

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Combined therapy for acute leukemia shows promising results

Unotron collaborates with GHA Technologies to supply washable data input devices

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in